Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… VIRACEPT (nelfinavir mesylate) Tablets, 625 mg, Agouron NDA 21-503 4/30/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S41 20-778/S20 & 21-503/S2 8/22/03 8/28/03 8/28/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S22 4/23/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S18 & 20-779/S39 | 12/20/02 7/30/03 4/4/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S16, 20-778/S17, 20-779/S37 & 20-779/S38 2/5/02 4/17/02 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S14, 20-779/S32 | VIRACEPT (nelfinavir mesylate) Tablets and Oral Powder, Pfizer Inc. Viracept (nelfinavir mesylate) 250 mg tablets, Pfizer | | Viracept (nelfinavir mesylate) 625 mg tablets, Pfizer | Viracept (nelfinavir mesylate) oral powder, Pfizer | VIRACEPT (nelfinavir mesylate) oral powder, Pfizer Inc., Labeling Revision | VIRACEPT (nelfinavir mesylate 250mg) tablets, Pfizer Inc., Labeling Revision | VIRACEPT (nelfinavir mesylate 625mg) tablets, Pfizer Inc., Labeling Revision | VIRACEPT (nelfinavir mesylate 625mg) Tablets, Agouron Pharma, Labeling Revision | VIRACEPT (nelfinavir mesylate) Oral Powder, Agouron Pharma, Labeling Revision | VIRACEPT (nelfinavir mesylate 250mg) Tablets, Agouron Pharma, Labeling Revision | VIRACEPT (nelfinavir mesylate 625mg) Tablets, Agouron Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com